NO960148D0 - Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike - Google Patents
Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slikeInfo
- Publication number
- NO960148D0 NO960148D0 NO960148A NO960148A NO960148D0 NO 960148 D0 NO960148 D0 NO 960148D0 NO 960148 A NO960148 A NO 960148A NO 960148 A NO960148 A NO 960148A NO 960148 D0 NO960148 D0 NO 960148D0
- Authority
- NO
- Norway
- Prior art keywords
- carbostyrils
- coumarins
- pct
- preparation
- drug containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4323409A DE4323409A1 (de) | 1993-07-13 | 1993-07-13 | Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel |
| PCT/EP1994/002251 WO1995002588A1 (de) | 1993-07-13 | 1994-07-09 | Verwendung von cumarinen und carbostyrilen als pla2-inhibitoren, neue cumarine und carbostyrile, verfahren zu ihrer herstellung und arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO960148D0 true NO960148D0 (no) | 1996-01-12 |
| NO960148L NO960148L (no) | 1996-03-12 |
Family
ID=6492685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO960148A NO960148L (no) | 1993-07-13 | 1996-01-12 | Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5716983A (no) |
| EP (1) | EP0708766B1 (no) |
| JP (1) | JPH08512057A (no) |
| KR (1) | KR960703887A (no) |
| CN (1) | CN1130381A (no) |
| AT (1) | ATE161010T1 (no) |
| AU (1) | AU686197B2 (no) |
| CA (1) | CA2167071A1 (no) |
| CZ (1) | CZ6896A3 (no) |
| DE (2) | DE4323409A1 (no) |
| FI (1) | FI960149A0 (no) |
| HU (1) | HUT73764A (no) |
| NO (1) | NO960148L (no) |
| NZ (1) | NZ268608A (no) |
| RU (1) | RU2133745C1 (no) |
| WO (1) | WO1995002588A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610728B2 (en) * | 1997-08-28 | 2003-08-26 | Eli Lilly And Company | Method for treatment of non-rheumatoid arthritis |
| HUP0102243A2 (hu) | 1998-05-01 | 2001-10-28 | Eli Lilly And Co. | sPLA2-inhibitor vegyületek betegség kezelésére |
| DE69910830T2 (de) * | 1998-12-30 | 2004-06-17 | Signal Pharmaceutical, Inc., San Diego | Verbindungen und verfahren zur modulation von estrogen rezeptoren |
| US6331562B1 (en) | 1998-12-30 | 2001-12-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| US6291456B1 (en) * | 1998-12-30 | 2001-09-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| US7027092B2 (en) * | 2001-09-17 | 2006-04-11 | Hewlett-Packard Development Company, L.P. | Image capture and storage device |
| AU2003230869B2 (en) | 2002-04-26 | 2010-02-25 | Ortho-Mcneil Pharmaceutical, Inc. | 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| KR20040001144A (ko) * | 2002-06-27 | 2004-01-07 | 김대경 | 신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법 |
| US7538233B2 (en) * | 2003-09-05 | 2009-05-26 | Aventis Pharmaceuticals Inc. | Coumarins as iNOS inhibitors |
| CN102532015B (zh) * | 2012-01-18 | 2013-10-23 | 云南大学 | 香豆素及其类似物的固相合成方法 |
| CN105687184A (zh) * | 2016-04-06 | 2016-06-22 | 梁海月 | 蛇床子素在制备治疗溃疡性结肠炎的药物方面的应用 |
| CN111423450B (zh) * | 2020-04-29 | 2021-10-26 | 上海天马有机发光显示技术有限公司 | 化合物、显示面板以及显示装置 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2035M (fr) * | 1962-06-29 | 1963-09-23 | Dausse Lab | Médicament a base de dérivé du méthyl-4 esculétol. |
| BE734121A (no) * | 1968-06-14 | 1969-11-17 | ||
| FR2276819A1 (fr) * | 1974-07-05 | 1976-01-30 | Fabre Sa Pierre | Facteurs p lipophile a action anti-inflammatoire locale utilisables dans le traitement de syndromes dermatologiques |
| JPS6056985A (ja) * | 1983-09-08 | 1985-04-02 | Sankyo Co Ltd | クマリン誘導体 |
| EP0165897B1 (de) * | 1984-05-24 | 1989-03-15 | Ciba-Geigy Ag | Neue Resorcinäther |
| IT1196133B (it) * | 1984-06-06 | 1988-11-10 | Ausonia Farma Srl | Derivati furanici con attivita' antiulcera |
| US5124334A (en) * | 1987-11-30 | 1992-06-23 | Du Pont Merck Pharmaceutical Company | Benzylalcohol phospholipase A2 inhibitors |
| FR2677023B1 (fr) * | 1991-05-30 | 1994-02-25 | Eurobio Laboratoires | Derives de coumarine hydrosolubles, leur preparation et leur utilisation comme substrat d'enzyme. |
| JPH06312925A (ja) * | 1993-03-02 | 1994-11-08 | Kureha Chem Ind Co Ltd | 軟骨保護剤及び新規エスクレチン誘導体 |
| US5534533A (en) * | 1993-10-01 | 1996-07-09 | Shionogi & Co., Ltd. | Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |
-
1993
- 1993-07-13 DE DE4323409A patent/DE4323409A1/de not_active Withdrawn
-
1994
- 1994-07-09 NZ NZ268608A patent/NZ268608A/en unknown
- 1994-07-09 AT AT94920981T patent/ATE161010T1/de not_active IP Right Cessation
- 1994-07-09 CN CN94193250A patent/CN1130381A/zh active Pending
- 1994-07-09 US US08/569,197 patent/US5716983A/en not_active Expired - Fee Related
- 1994-07-09 WO PCT/EP1994/002251 patent/WO1995002588A1/de not_active Application Discontinuation
- 1994-07-09 AU AU71880/94A patent/AU686197B2/en not_active Ceased
- 1994-07-09 RU RU96102842A patent/RU2133745C1/ru active
- 1994-07-09 DE DE59404786T patent/DE59404786D1/de not_active Expired - Fee Related
- 1994-07-09 JP JP7503693A patent/JPH08512057A/ja active Pending
- 1994-07-09 EP EP94920981A patent/EP0708766B1/de not_active Expired - Lifetime
- 1994-07-09 HU HU9503973A patent/HUT73764A/hu unknown
- 1994-07-09 CA CA002167071A patent/CA2167071A1/en not_active Abandoned
- 1994-07-09 CZ CZ9668A patent/CZ6896A3/cs unknown
- 1994-07-09 KR KR1019960700230A patent/KR960703887A/ko not_active Application Discontinuation
-
1996
- 1996-01-12 NO NO960148A patent/NO960148L/no not_active Application Discontinuation
- 1996-01-12 FI FI960149A patent/FI960149A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2133745C1 (ru) | 1999-07-27 |
| NZ268608A (en) | 1997-09-22 |
| HU9503973D0 (en) | 1996-03-28 |
| EP0708766B1 (de) | 1997-12-10 |
| KR960703887A (ko) | 1996-08-31 |
| FI960149A (fi) | 1996-01-12 |
| AU7188094A (en) | 1995-02-13 |
| WO1995002588A1 (de) | 1995-01-26 |
| ATE161010T1 (de) | 1997-12-15 |
| JPH08512057A (ja) | 1996-12-17 |
| CA2167071A1 (en) | 1995-01-26 |
| HUT73764A (en) | 1996-09-30 |
| AU686197B2 (en) | 1998-02-05 |
| CZ6896A3 (en) | 1996-04-17 |
| DE4323409A1 (de) | 1995-01-19 |
| US5716983A (en) | 1998-02-10 |
| CN1130381A (zh) | 1996-09-04 |
| EP0708766A1 (de) | 1996-05-01 |
| FI960149A0 (fi) | 1996-01-12 |
| DE59404786D1 (de) | 1998-01-22 |
| NO960148L (no) | 1996-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK41193D0 (da) | Ionkanalaabnere | |
| DZ1794A1 (fr) | Nouvelle formule pharmaceutique. | |
| NO914356L (no) | Mono n-substituerte 1,4,7,10-tetraazacyklododekanderivater, fremgangsmaater for fremstilling av dem og farmasoeytiskemidler som inneholder dem | |
| BR9408246A (pt) | Composto derivado de 3-azabicicloalcano N-substituído | |
| FI972062A0 (fi) | Substituoituja 4-biaryylivoi- tai 5-biaryylipentaanihappoja ja johdannaisia matriisimetalliproteaasi-inhibiittoreina | |
| PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
| DK0707591T3 (da) | Methylphosphonsyreestere, fremgangsmåde til deres fremstilling samt deres anvendelse | |
| NO960148L (no) | Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike | |
| DE69332259D1 (de) | Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung | |
| FI962323A0 (fi) | N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit | |
| IL107520A0 (en) | Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them | |
| DK0731801T3 (da) | Substituerede aminoaylkylaminopyridiner | |
| AU6930494A (en) | Indole derivatives as steroid 5alpha-reductase inhibitors | |
| ATE144986T1 (de) | Aminoacylderivate von gem- diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten | |
| KR960700223A (ko) | C-치환 디에틸렌 트리아민의 제조 방법(Process for the Production of C-Substituted Diethylenetriamines) | |
| EE03488B1 (et) | Meetod anhüdroekgoniini estrite valmistamiseks | |
| DE69215511D1 (de) | Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen | |
| NO961657L (no) | Dibenz[b,eÅoksepinderivater, fremgangsmåte for fremstilling samt legemiddel inneholdende slike |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |